{"entity":{"id":"steven-rosen","kind":"person","name":"Steven T. Rosen","aka":[],"tldr":"Steven Rosen is a lymphoma specialist who directs City of Hope's research enterprise.","summary":"Steven Rosen is Provost and Chief Scientific Officer of City of Hope and Director of its Beckman Research Institute, having previously directed Northwestern's Lurie Cancer Center for 25 years. A haematologist-oncologist specialising in lymphoma and translational science, he leads Beckman Research Institute and City of Hope's comprehensive cancer centre designation. His papers include a Blood Reviews article on primary cutaneous lymphomas and their treatment options and a Blood phase II trial of 2-chlorodeoxyadenosine for cutaneous T-cell lymphoma. His work links lymphoma research, including diffuse large B-cell lymphoma, to cancer research leadership.","asOf":"2026-09-08","wikipedia":"https://en.wikipedia.org/wiki/Steven_T._Rosen","links":[{"label":"City of Hope research faculty","url":"https://www.cityofhope.org/research/find-a-researcher"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Rosen%20ST%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Steven%20T.%20Rosen"}],"tags":[],"related":[],"cancers":["dlbcl"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["city-of-hope"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Provost and Chief Scientific Officer; Director, Beckman Research Institute, City of Hope","institutionId":"city-of-hope","specialisms":["Lymphoma","Cancer research leadership","Translational science"],"profiles":[{"label":"City of Hope research faculty","url":"https://www.cityofhope.org/research/find-a-researcher"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Rosen%20ST%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Steven%20T.%20Rosen"}],"papers":[{"title":"Primary cutaneous lymphomas: a review with current treatment options","journal":"Blood Reviews","year":2003,"url":"https://doi.org/10.1016/s0268-960x(03)00004-3","doi":"10.1016/s0268-960x(03)00004-3"},{"title":"Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma","journal":"Blood","year":1996}],"orcid":"0000-0002-8818-7724"},"route":"/people/steven-rosen/","neighbours":{"cancer":[{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"}],"institution":[{"id":"city-of-hope","kind":"institution","name":"City of Hope","route":"/institutions/city-of-hope/"}]}}